Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Benatar
Avraham Benatar, Upper Arlington, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20080314498 | Apparatus and Method for Ultrasonic Processing of Laminates - A method for ultrasonic debulking a composite laminate ( | 12-25-2008 |
| 20110114247 | Apparatus and Method for Ultrasonic Processing of Laminates - A method for ultrasonic debulking a composite laminate includes the steps of defining a path across the laminate, the path having a starting location and an ending location and applying a force to and transmitting ultrasonic vibration into the laminate along the path, beginning at the starting location and ending at the ending location. The method further includes determining a temperature of a surface of the laminate proximate to the path and varying at least one of an amplitude of the ultrasonic vibration, the applied force, a feed rate at which the force and the ultrasonic vibration are applied along the path, an angle at which the ultrasonic vibration is applied to the laminate, and an interval at which plies of the laminate are processed, based upon the determined temperature of the surface of the laminate. | 05-19-2011 |
Lisa Benatar, Palo Alto, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100229919 | Device for supporting and reversibly attaching and detaching photovoltaic modules - A device for the support of photovoltaic modules such that the tilt angles of the photovoltaic modules can be varied to modify the exposure of the photovoltaic modules to sunlight for the purpose of generating solar electricity. The device allows for the reversible attachment and detachment of photovoltaic modules, serves as the storage for the photovoltaic modules when the photovoltaic modules are detached, and is easily portable by a single person. | 09-16-2010 |
Rafi Benatar, Kochav Yair IL
| Patent application number | Description | Published |
|---|---|---|
| 20120087622 | Mechanical Optical Switch - A mechanical fiber optic switch including a plurality of first optical fibers, having optical interface ends distributed along a longitudinal axis in a plurality of longitudinal levels, two or more of the longitudinal levels including a plurality of optical interface ends in different radial angles. In addition, the switch includes a plurality of second fibers movable relative to the longitudinal axis, such that each of the second fibers can be optically coupled with the optical interface ends of first fibers in a specific respective radial angle. A fiber gripper is adapted to move the second fibers and a movement mechanism is adapted to move the fiber gripper along the longitudinal axis and to achieve relative rotation of the fiber gripper around the longitudinal axis. | 04-12-2012 |
Vidal Benatar, Saint-Cloud FR
| Patent application number | Description | Published |
|---|---|---|
| 20080200450 | Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction - Use of ivabradine, or 3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]-methyl}-(methyl)-amino]-propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one, its addition salts with a pharmaceutically acceptable acid and their hydrates, for obtaining a medicament intended for the treatment of endothelial dysfunction. | 08-21-2008 |
| 20090215745 | Association of a sinus node If current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it - Association comprising a selective and specific sinus node I | 08-27-2009 |
| 20110230466 | Association of a sinus node if current inhibitor and calcium inhibitor and pharmaceutical compositions containing it - Association comprising a selective and specific sinus node I | 09-22-2011 |
| 20110288072 | Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction - Use of ivabradine, or 3-{3-[{[(7S)-3,4-dimethoxybicyclo [4.2.0]octa-1,3,5-trien-7-yl]-methyl }-(methyl)-amino]-propyl}-7,8-dimethoxy-1,3,4,5 -tetrahydro-2H-3-benzazepin-2-one, its addition salts with a pharmaceutically acceptable acid and their hydrates, for obtaining a medicament intended for the treatment of endothelial dysfunction. | 11-24-2011 |